The market for natural dietary supplements is booming and Chr. Hansen will present its growing portfolio of products at this year’s Vitafoods Europe, with focus on the ground-breaking technology LIFE GEL®, and the award-nominated product solution Mother’s 1st.
A patent-pending industry first
The LIFE GEL® technology is the world’s first soft gel solution that can sustain live probiotics for two years on the shelf. It combines probiotics and Omega-3 and in the popular soft gel dosage form the platform opens op for countless business opportunities.
To demonstrate how LIFE GEL® can be used to target a specific market segment, Chr. Hansen has developed Mother’s 1st, a solution for pregnant and lactating women. At the end of shelf life, this white-colored soft gel contains 1 billion of the world’s best-documented bifidobacteria, Chr. Hansen’s probiotic strain named
BB-12®, and 250 mg of DHA. Mother’s 1st has been nominated as a finalist in the “Finished product of the year – Immune category”, in this year’s NutraIngredients Awards at Vitafoods.
Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition Division, says: “This nomination confirms that combining science and our industry-leading technology is the perfect recipe for meeting consumers’ need for convenient solutions. We are very proud of Mother’s 1st and we are looking forward to discussing its many benefits with potential partners at Vitafoods”.
At a seminar on May 6, Chr. Hansen will present the LIFE GEL®technology platform and its many business opportunities:
Time: 6 May, 2015 at 15:10 – 15:40
Place: Exhibitor Presentation Theatre, Palexpo, Geneva, Switzerland
A wide range of products
Apart from LIFE GEL®, Chr. Hansen will also be showcasing its many innovative product concepts, such as probiotic oil drops for infants and young children, probiotic shots for gastrointestinal function and regularity, and various combination products.
Vitafoods Europe 2015 takes place in Geneva, Switzerland May 5-7. You will find Chr. Hansen at booth number I62.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.